| Epidemiology and costs of chronic obstructive pulmonary disease KR Chapman, DM Mannino, JB Soriano, PA Vermeire, AS Buist, MJ Thun, ... European Respiratory Journal 27 (1), 188-207, 2006 | 1142 | 2006 |
| Outcomes for COPD pharmacological trials: from lung function to biomarkers M Cazzola, W MacNee, FJ Martinez, KF Rabe, LG Franciosi, PJ Barnes, ... European respiratory journal 31 (2), 416-469, 2008 | 1055 | 2008 |
| Geographic variations in prevalence and underdiagnosis of COPD: results of the IBERPOC multicentre epidemiological study VS Penña, M Miravitlles, R Gabriel, CA Jiménez-Ruiz, C Villasante, ... Chest 118 (4), 981-989, 2000 | 1036 | 2000 |
| Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities M Miravitlles, JB Soriano, F Garcia-Rio, L Muñoz, E Duran-Tauleria, ... Thorax 64 (10), 863-868, 2009 | 845 | 2009 |
| Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study M Miravitlles, M Ferrer, A Pont, R Zalacain, JL Alvarez-Sala, F Masa, ... Thorax 59 (5), 387-395, 2004 | 713 | 2004 |
| Health outcomes following treatment for 6 months with once daily tiotropium compared with twice daily salmeterol in patients with COPD V Brusasco, R Hodder, M Miravitlles, L Korducki, L Towse, S Kesten Thorax 58 (5), 399-404, 2006 | 667 | 2006 |
| Relationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPD M Miravitlles, C Espinosa, E Fernández-Laso, JA Martos, JA Maldonado, ... Chest 116 (1), 40-46, 1999 | 617 | 1999 |
| Management of COPD exacerbations: a European respiratory society/American thoracic society guideline JA Wedzicha, M Miravitlles, JR Hurst, PMA Calverley, RK Albert, ... European Respiratory Journal 49 (3), 2017 | 553 | 2017 |
| An official American Thoracic Society/European Respiratory Society statement: research questions in chronic obstructive pulmonary disease BR Celli, M Decramer, JA Wedzicha, KC Wilson, A Agustí, GJ Criner, ... American journal of respiratory and critical care medicine 191 (7), e4-e27, 2015 | 547 | 2015 |
| Symptom variability in patients with severe COPD: a pan-European cross-sectional study R Kessler, MR Partridge, M Miravitlles, M Cazzola, C Vogelmeier, ... European Respiratory Journal 37 (2), 264-272, 2011 | 540 | 2011 |
| Efficacy and tolerability of budesonide/formoterol added to tiotropium in patients with chronic obstructive pulmonary disease T Welte, M Miravitlles, P Hernandez, G Eriksson, S Peterson, ... American journal of respiratory and critical care medicine 180 (8), 741-750, 2009 | 538 | 2009 |
| Factors associated with increased risk of exacerbation and hospital admission in a cohort of ambulatory COPD patients: a multiple logistic regression analysis M Miravitlles, T Guerrero, C Mayordomo, L Sánchez-Agudo, F Nicolau, ... Respiration 67 (5), 495-501, 2000 | 475 | 2000 |
| Determinants of underdiagnosis of COPD in national and international surveys B Lamprecht, JB Soriano, M Studnicka, B Kaiser, LE Vanfleteren, ... Chest 148 (4), 971-985, 2015 | 411 | 2015 |
| Interpretation of quality of life scores from the St George's Respiratory Questionnaire M Ferrer, C Villasante, J Alonso, V Sobradillo, R Gabriel, G Vilagut, ... European Respiratory Journal 19 (3), 405-413, 2002 | 401 | 2002 |
| Costs of chronic bronchitis and COPD: a 1-year follow-up study M Miravitlles, C Murio, T Guerrero, R Gisbert, DAFNE Study Group Chest 123 (3), 784-791, 2003 | 382 | 2003 |
| Consensus document on the overlap phenotype COPD–asthma in COPD JJ Soler-Cataluna, B Cosío, JL Izquierdo, JL López-Campos, JM Marín, ... Archivos de Bronconeumología (English Edition) 48 (9), 331-337, 2012 | 375 | 2012 |
| What is asthma− COPD overlap syndrome? Towards a consensus definition from a round table discussion DD Sin, M Miravitlles, DM Mannino, JB Soriano, D Price, BR Celli, ... European Respiratory Journal 48 (3), 664-673, 2016 | 373 | 2016 |
| Pharmacoeconomic evaluation of acute exacerbations of chronic bronchitis and COPD M Miravitlles, C Murio, T Guerrero, R Gisbert, DAFNE Study Group Chest 121 (5), 1449-1455, 2002 | 366 | 2002 |
| Understanding the impact of symptoms on the burden of COPD M Miravitlles, A Ribera Respiratory research 18 (1), 1-11, 2017 | 365 | 2017 |
| Clinical phenotypes of COPD: identification, definition and implications for guidelines M Miravitlles, M Calle, JJ Soler-Cataluña Archivos de Bronconeumología (English Edition) 48 (3), 86-98, 2012 | 356 | 2012 |
Antonio AnzuetoProfessor of Medicine在 uthscsa.edu 的电子邮件经过验证
